Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEDIPASVIR\SOFOSBUVIR vs LENACAPAVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEDIPASVIR\SOFOSBUVIR vs LENACAPAVIR: Safety Overview

Metric LEDIPASVIR\SOFOSBUVIR LENACAPAVIR
Total FAERS Reports 23,616 502
Deaths Reported 1,371 32
Death Rate 5.8% 6.4%
Hospitalizations 4,031 42
Average Patient Age 57.9 yrs 50.0 yrs
% Female Patients 42.9% 24.7%
FDA Approval Date N/A Dec 22, 2022
Manufacturer N/A Gilead Sciences, Inc.
Route N/A ORAL
Marketing Status N/A Prescription